Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-11

Clinical Trial Update: Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers

View source ↗

Summary

Clinical trial comparing Pradaxa (dabigatran) with warfarin in atrial fibrillation and assessing effects on bone mass and bone turnover markers; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pradaxa (dabigatran etexilate)
  • Warfarin (warfarin)

Snippet

Sponsor: UConn Health | Conditions: Atrial Fibrillation | Status: TERMINATED